The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015. Australia hasn’t followed suit, though flib
“I’m a twin, so when my sister got her period first (even thought I hadn’t yet gotten mine), I stepped up to the plate to be helpful. She was having trouble figuring out just how the hell you’re supposed to just ‘STICK IT IN!?’ so we were in the bathroom...